MDR 3.45% 30.0¢ medadvisor limited

They had to get something out this week. Looks like the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,108 Posts.
    lightbulb Created with Sketch. 84
    They had to get something out this week. Looks like the quarterly was ready first.

    I too would have assumed we'd hit 1M by the end of December.

    The 2016 December quarterly quoted 600k users. With only 35k added in the last 3 months suggests they may be reaching saturation under their current model. EBOS has arrived just in time.

    With the MOU waiting to go binding, the benefits with using EBOS to promote MDR will really only hit the bottom line in the EOFY Report. There's reference to a separate announcement once agreements are final. I'm now thinking February.

    Despite the really good news, 25% increase in revenue from the last quarter, more PEP customers, more users, growing patient numbers per pharmacy and increased use of tap-t0-refill the market appears to be waiting for the agreement to be formalised and a detailed understanding of the terms, conditions and financial benefits that will come with EBOS (HPS, Zest, Terry White Chemart Pharmacies).

    Also noticed the volume at 6c disappeared. Perhaps they want to sell higher and pulled their order or perhaps it expired as it was there for a couple weeks.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 30.0¢ 27.5¢ $254.8K 889.6K

Buyers (Bids)

No. Vol. Price($)
2 39326 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 2917 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.